Hypertension

High blood pressure increases a patient's risk of heart attack, stroke and other diseases. Most people with hypertension have no symptoms. The Centers for Disease Control and Prevention (CDC) says nearly half of U.S. adults have hypertension, or high blood pressure, and only about 1 in 4 of those individuals has their hypertension under control. The World Health Organization (WHO) expects the epidemic of hypertension world-wide will exceed 1.56 billion people by 2025. Major efforts are underway to better control this primary risk factor through screenings, medication and invasive procedures such as renal denervation in severely uncontrolled patients.

World Health Organization urges countries to limit salt intake to reduce risk of CVD, hypertension
The group wants countries to implement population-wide changes that can keep salt intake to a minimum. It estimates that such policies could save up to 900,000 lives in just a few years.
Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension
The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms.
FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck
Cardiologists now have two more tools to help them combat PAH, a rare vascular condition that often leads to heart failure.
FDA approves new hypertension drug months after Idorsia reacquired rights for $343M
Aprocitentan, sold under the brand name Tryvio, is approved for patients with high blood pressure who are already taking other antihypertensive drugs.
World’s first patient treated with new implantable device for pulmonary hypertension
The procedure, performed on Feb. 14, was part of an early feasibility trial developed with help from the FDA.

Renal denervation linked to significant drops in blood pressure

Two late-breaking clinical trials presented May 23 at EuroPCR in London demonstrated the ability of renal denervation to significantly lower patients’ blood pressures, regardless of whether they were taking antihypertensive medications.

May 23, 2018

Medtronic Announces Renal Denervation Pivotal Trial for the Treatment of Hypertension

DUBLIN — April 9, 2018 — Medtronic plc (NYSE:MDT) today announced U.S. Food and Drug Administration (FDA) approval to begin an investigational device exemption (IDE) pivotal trial to evaluate the Symplicity Spyral(TM) renal denervation system in patients with high blood pressure (hypertension).

April 9, 2018

Reducing racial segregation one way to fight hypertension in black adults

Research has linked greater segregation within black communities can lead to higher prevalence of hypertension. A recent study, published online May 15 in JAMA Internal Medicine, examined how changes in exposure to segregation affected high blood pressure.

May 16, 2017

Around the web

Health Imaging

New imaging protocols proposed to curb rise of cardiovascular infections

Eleven medical societies have signed on to a consensus statement aimed at standardizing imaging for suspected cardiovascular infections.

Radiology Business

What does radiology have to do with climate change?

Kate Hanneman, MD, explains why many vendors and hospitals want to lower radiology's impact on the environment. "Taking steps to reduce the carbon footprint in healthcare isn’t just an opportunity," she said. "It’s also a responsibility."

Hypertension

World Health Organization urges countries to limit salt intake to reduce risk of CVD, hypertension

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

FDA approves new drugs for pulmonary arterial hypertension from Johnson & Johnson, Merck

FDA approves new hypertension drug months after Idorsia reacquired rights for $343M

World’s first patient treated with new implantable device for pulmonary hypertension

Around the web